secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amneal Pharmaceuticals, Inc. (AMRX)
CIK:        0001723128
Form:       8-K
Filed at:   2023-12-15T23:59:59+00:00
Accession:  0001193125-23-296658
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amneal to transfer stock exchange listing from NYSE to Nasdaq effective Dec 27, 2023
--------------------------------------------------------------------------------

- Listing on NYSE ends at market close Dec 26; Nasdaq trading starts at market open Dec 27.
- Common stock will continue to trade under symbol AMRX and join Nasdaq Composite and Nasdaq Biotechnology Index.
- Voluntary delisting from NYSE approved by Board; no change in business operations or shareholder rights.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1723128/000119312523296658/0001193125-23-296658-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1723128/000119312523296658/d65273d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-296658

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer